Mai Abd El-Meguid

Mai Abd El-Meguid

Auto-generated profile, based on publicly available information

Mai Abd El-Meguid

Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Giza, P.O. 12622, Egypt

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Genes & Diseases
Verified
Journal Article
Open access
GSGhada Salum
Ghada Salum
RDReham Dawood
Reham Dawood
MEMai Abd El-Meguid
Mai Abd El-Meguid
NINoha E. Ibrahim
Noha E. Ibrahim
AAAshraf O. Abdel Aziz
Ashraf O. Abdel Aziz
MAMostafa K. El Awady
Mostafa K. El Awady
In Egypt, Sofosbuvir (SOF) in combination with Dataclasvir (DCV) is the broadly used DAAs with excellent therapeutic profile. This study is designed to explore the relation between IL28B/TLR4 genetic variants and each of the followings; HCC development post SOF/DCV treatment, progression to HCC in naïve patients and SOF/DCV therapy outcome. A total of 493 blood samples were collected (controls (n = 70); HCV patients treated with SOF/DCV (n = 252) of whom 65 patients developed HCC, 187 patients didn't develop HCC (125 responders, 62 relapsers); naïve HCV patients (n = 171) had early (n = 48), late liver fibrosis (n = 21) and HCC (n = 102)). Both SNPs were genotyped using a TaqMan 5′ allelic discrimination assay. At IL28B rs12979860 SNP, the C allele was significantly correlating with the response rate more than T allele (OR 1.9, 95% CI 1.29–2.9, p = 0.004), while at TLR4 rs4986791 SNP, no association was found (OR 6.5, 95% 0.57–75.28, p = 0.09). Both SNPs couldn't detect the probability for HCC emergence after treatment. In naïve patients, the protective alleles were detected in their lowest frequency in HCC patients (p = 0.1, for rs12979860 and, p = 0.001 for rs4986791). SOF/DCV combination improved SVR rates in HCV genotype 4a infected patients regardless of IL28B genotype, with the best rates in those lacking the T allele.

22 December 2010 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
NDNoha G Bader El Din
Noha G Bader El Din
MMMai Abd El Meguid
Mai Abd El Meguid
Ashraf TabllAshraf Tabll
Ashraf Tabll
MAMohamed Mohamed Anany
Mohamed Mohamed Anany
GEGamal Esmat
Gamal Esmat
MAMostafa El Awady
Mostafa El Awady

1 August 2018 in Journal of Interferon & Cytokine Research
Verified
Journal Article
Closed access
MEMai Abd El-Meguid
Mai Abd El-Meguid
RDReham M. Dawood
Reham M. Dawood
MMMohamed Aly Mokhles
Mohamed Aly Mokhles
MAMostafa K. El Awady
Mostafa K. El Awady
Elevated levels of transforming growth factor-β (TGF-β) family mediate myofibroblast generation and extracellular matrix deposition, thus making TGF-β recognized as major profibrogenic cytokines. In this article, we provide evidence that extrahepatic TGF-β2 expression at RNA and protein levels in peripheral leucocytes and serum, respectively, correlate with hepatic fibrogenesis. Current study includes a total of 110 subjects [89 naive hepatitis C virus (HCV)-infected patients (f0–f4) and 21 healthy controls]. Array profiling of 84 fibrosis-related transcripts revealed that TGF-β2 RNA was significantly upregulated compared with controls. Transcription results were confirmed by specific qRT-PCR on TGF-β2 RNA in peripheral leucocytes and TGF-β2 protein by ELISA in serum. PCR array and qRT-PCR for TGF-β2 RNA in peripheral leucocytes revealed that HCV-infected patients, regardless of the degree of fibrosis, had significantly elevated TGF-β2 RNA levels compared with controls (P = 0.018 and 0.047, respectively). This extrahepatic upregulation of TGF-β2 RNA was confirmed by elevated levels of secretory TGF-β2 protein in infected sera (P = 0.001). The Area Under the Curve of the receiver operating characteristic curve for the TGF-β2 protein between patients and controls was 0.80, a value that renders serum TGF-β2 protein a promising biomarker for liver fibrosis.

20 July 2018 in Gene
Verified
Journal Article
Closed access
RDReham Dawood
Reham Dawood
MEMai Abd El-Meguid
Mai Abd El-Meguid
MIMarwa K. Ibrahim
Marwa K. Ibrahim
NDNoha G. Bader El Din
Noha G. Bader El Din
ABAhmed Barakat
Ahmed Barakat
MAMostafa K. El Awady
Mostafa K. El Awady

9 September 2025 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
MEMai Abd El-Meguid
Mai Abd El-Meguid
GSGhada M. Salum
Ghada M. Salum
BFBasma E. Fotouh
Basma E. Fotouh
NZNaglaa Zayed
Naglaa Zayed
SAShereen Abdel Alem
Shereen Abdel Alem
RDReham M. Dawood
Reham M. Dawood